Following on Protein Arrays, NextGen Plans to Offer a 2D Gel Platform of Its Own | GenomeWeb

In an effort to live up to its name, NextGen Sciences has begun developing what it hopes will be the next generation of 2D gel electrophoresis analysis systems. Last week, the Huntingdon, UK-based company won a £150,000 ($280,000) SMART grant from the UK government to help fund its product development activities, and NextGen plans to complete a beta version of its new platform by the end of the year, according to Linda Cammish, NextGen’s director of business development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.